Search Orphan Drug Designations and Approvals
-
Generic Name: | 8-((6-iodobenzo[d][1,3]dioxol-5-yl)thio)-9-(2-(neopentylamino)ethyl)-9H-purin-6-amine, dihydrochloride salt |
---|---|
Date Designated: | 06/06/2022 |
Orphan Designation: | Treatment of Malignant Glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Samus Therapeutics, Inc. 10 South Main Street Topsfield, Massachusetts 01983 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-